Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

For cancer treatment, a new gene would be introduced into cancer cells. This would either cause the cancer cells to die off or prevent them from growing. CRISPR is an example of gene editing that ...

will be investigating the method’s safety and tolerability in patients with non-small cell lung cancer (NSCLC) whose disease has progressed after previous standard treatment. The CRISPR-Cas9 ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.